(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide

C105H121ClF2N26O12 — CID 157192860

IUPAC(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide
SMILESCC[C@@H](CC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccc(C)nc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1cc(F)ccc1F.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccc(C)nc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccccc1Cl
InChIInChI=1S/C27H33N7O3.C26H29ClN6O3.C26H28F2N6O3.C26H31N7O3/c1-6-19(20-8-7-16(2)30-15-20)14-23(35)34-24(26(37)33(5)27-29-9-10-32(27)4)21(25(34)36)12-18-11-17(3)31-22(28)13-18;1-4-17(18-7-5-6-8-20(18)27)15-22(34)33-23(25(36)32(3)26-30-11-12-31(26)2)19(24(33)35)13-16-9-10-29-21(28)14-16;1-4-16(18-14-17(27)5-6-20(18)28)13-22(35)34-23(25(37)33(3)26-31-9-10-32(26)2)19(24(34)36)11-15-7-8-30-21(29)12-15;1-5-18(19-7-6-16(2)30-15-19)14-22(34)33-23(25(36)32(4)26-29-10-11-31(26)3)20(24(33)35)12-17-8-9-28-21(27)13-17/h7-11,13,15,19,21,24H,6,12,14H2,1-5H3,(H2,28,31);5-12,14,17,19,23H,4,13,15H2,1-3H3,(H2,28,29);5-10,12,14,16,19,23H,4,11,13H2,1-3H3,(H2,29,30);6-11,13,15,18,20,23H,5,12,14H2,1-4H3,(H2,27,28)/t19-,21+,24-;17-,19+,23-;16-,19+,23-;18-,20+,23-/m0000/s1
InChIKeyAPXDSKNLIVSNHM-BVRUFQATSA-N
MW2012.74 g/mol
LogP10.81
Rot. Bonds32

About (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide

(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide (PubChem CID 157192860) has the molecular formula C105H121ClF2N26O12 and a molecular weight of 2012.74 g/mol. Its IUPAC name is (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide.

Molecular Properties

Compound Name(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide
PubChem CID157192860
Molecular FormulaC105H121ClF2N26O12
Molecular Weight2012.74 g/mol
Exact Mass2010.93
IUPAC Name(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide
SMILESCC[C@@H](CC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccc(C)nc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1cc(F)ccc1F.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccc(C)nc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccccc1Cl
InChIInChI=1S/C27H33N7O3.C26H29ClN6O3.C26H28F2N6O3.C26H31N7O3/c1-6-19(20-8-7-16(2)30-15-20)14-23(35)34-24(26(37)33(5)27-29-9-10-32(27)4)21(25(34)36)12-18-11-17(3)31-22(28)13-18;1-4-17(18-7-5-6-8-20(18)27)15-22(34)33-23(25(36)32(3)26-30-11-12-31(26)2)19(24(33)35)13-16-9-10-29-21(28)14-16;1-4-16(18-14-17(27)5-6-20(18)28)13-22(35)34-23(25(37)33(3)26-31-9-10-32(26)2)19(24(34)36)11-15-7-8-30-21(29)12-15;1-5-18(19-7-6-16(2)30-15-19)14-22(34)33-23(25(36)32(4)26-29-10-11-31(26)3)20(24(33)35)12-17-8-9-28-21(27)13-17/h7-11,13,15,19,21,24H,6,12,14H2,1-5H3,(H2,28,31);5-12,14,17,19,23H,4,13,15H2,1-3H3,(H2,28,29);5-10,12,14,16,19,23H,4,11,13H2,1-3H3,(H2,29,30);6-11,13,15,18,20,23H,5,12,14H2,1-4H3,(H2,27,28)/t19-,21+,24-;17-,19+,23-;16-,19+,23-;18-,20+,23-/m0000/s1
InChIKeyAPXDSKNLIVSNHM-BVRUFQATSA-N
XLogP10.81
TPSA483.46 Ų
H-Bond Donors4
H-Bond Acceptors30
Rotatable Bonds32
Heavy Atoms146
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002012.74
LogP ≤ 510.81
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1030

Analyze (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide?
The IUPAC name of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide (CID 157192860) is (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide.
What is the SMILES notation for (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide?
The canonical SMILES for (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide is CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccc(C)nc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1cc(F)ccc1F.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccc(C)nc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccccc1Cl.
What is the InChIKey of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide?
The InChIKey is APXDSKNLIVSNHM-BVRUFQATSA-N. The full InChI is InChI=1S/C27H33N7O3.C26H29ClN6O3.C26H28F2N6O3.C26H31N7O3/c1-6-19(20-8-7-16(2)30-15-20)14-23(35)34-24(26(37)33(5)27-29-9-10-32(27)4)21(25(34)36)12-18-11-17(3)31-22(28)13-18;1-4-17(18-7-5-6-8-20(18)27)15-22(34)33-23(25(36)32(3)26-30-11-12-31(26)2)19(24(33)35)13-16-9-10-29-21(28)14-16;1-4-16(18-14-17(27)5-6-20(18)28)13-22(35)34-23(25(37)33(3)26-31-9-10-32(26)2)19(24(34)36)11-15-7-8-30-21(29)12-15;1-5-18(19-7-6-16(2)30-15-19)14-22(34)33-23(25(36)32(4)26-29-10-11-31(26)3)20(24(33)35)12-17-8-9-28-21(27)13-17/h7-11,13,15,19,21,24H,6,12,14H2,1-5H3,(H2,28,31);5-12,14,17,19,23H,4,13,15H2,1-3H3,(H2,28,29);5-10,12,14,16,19,23H,4,11,13H2,1-3H3,(H2,29,30);6-11,13,15,18,20,23H,5,12,14H2,1-4H3,(H2,27,28)/t19-,21+,24-;17-,19+,23-;16-,19+,23-;18-,20+,23-/m0000/s1.
What are the key properties of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide?
(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide has a molecular weight of 2012.74 g/mol, XLogP of 10.81, 32 rotatable bonds, 4 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2-chlorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-(2,5-difluorophenyl)pentanoyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-1-[(3S)-3-(6-methyl-3-pyridinyl)pentanoyl]-4-oxoazetidine-2-carboxamide is sourced from PubChem (CID 157192860), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).